Approval · Notice of Compliance 11684 · 2010
MYLAN-PINDOLOL: Notice of Compliance 11684
Issued August 25, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11684
- Date
- August 25, 2010
- Company
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Antihypertensive / Antianginal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYLAN-PINDOLOL | 02057808 | Cancelled Post Market |
| MYLAN-PINDOLOL | 02057816 | Cancelled Post Market |